The Caris Life Sciences® Board of Directors is responsible for the overall management of the company, including guiding strategies and monitoring company performance. The Caris Board is composed of a diverse group of leaders with distinct perspectives. Many of the current directors have held leadership roles at major domestic and international companies, academic and scientific organizations, and governmental agencies.
The Caris Life Sciences® Management Team is empowered by the Board of Directors to manage and oversee company operations, and execute strategies set by the Board. The Management Team is composed of a diverse group of leaders with experiences spanning business, finance, medical, scientific, and technical services.
The Scientific Advisory Board is comprised of external thought leaders who provide independent opinions and recommendations about Caris Life Sciences® initiatives and offerings. The Scientific Advisory Board members are experts in contemporary cancer research, drug and diagnostic development, clinical trial design, regulatory issues and reimbursement policy, as well as clinical oncologists from both the community and academic medical center settings.
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center
Deputy Director, University of Cincinnati Cancer Institute and The Barrett Cancer Center
Professor, Computational Biology and Bioinformatics, Harvard School of Public Health